Clinical Trial

A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems

Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to investigate the efficacy and safety of Lipase Thera-blend and Lipase Thera-blend + tributyrin on memory in healthy adults with self-reported memory problems. The main question\[s\] it aims to answer \[is/are\]: Does of Lipase Thera-blend improve memory in healthy adults? Does Lipase Thera-blend + tributyrin improve memory in healthy adults? Researchers will compare Lipase Thera-blend and Lipase Thera-blend + tributyrin against a placebo to see if the investigational products improve memory parameters. Participants will be asked to consume either placebo, Lipase Thera-blend, or Lipase Thera-blend + tributyrin and asked to complete memory questionnaires to assess memory.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-05; most recent amendment 2026-03-27.
Status change: Recruiting → Completed 2026-03-27
Status change: Not Yet Recruiting → Recruiting 2025-09-02
Trial Details
NCT Number NCT07020494
Lead Sponsor Enzymedica
Collaborators: KGK Science Inc.
Conditions Self-reported Memory Problems, Memory
Enrollment 90 participants
Start Date 2025-08-25
Primary Completion 2026-02-13 (estimated)
Study Completion 2026-02-13 (estimated)
Updated on ClinicalTrials.gov 2026-03-31